Retraction

Long non-coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA-143-3p/c-MET axis

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1111/jcmm.18102

Citations (18)

18
Total Citations
2
Post-Retraction
(11.1%)
16
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
337 Days since retraction (latest)
Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia
Parminder Kaur, Pankaj Sharma, Prateek Bhatia et al. (4 authors)
Discover Oncology Open Access
Published: Nov 2024
337 days after retraction
MiR-144-3p regulates invasion and proliferation activity in hepatocellular carcinoma by targeting SLITRK4
Dongdong Xiao, Haibo Xu, Jianchun Li et al. (7 authors)
International Journal of Radiation Research
Published: Apr 2024
95 days after retraction
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
Xinhe Shan, Qi Long, Alfred L. Garfall et al. (4 authors)
Blood Cancer Journal Open Access
Published: May 2023
220 days before retraction
Long non‑coding RNAs in multiple myeloma (Review)
Chenbo Yang, Yinghao Liang, Jiao Shu et al. (7 authors)
International Journal of Oncology Open Access
Published: May 2023
9 citations
238 days before retraction
Crosstalk between SOX Genes and Long Non-Coding RNAs in Glioblastoma
Milena Stevanović, Nataša Kovačević‐Grujičić, Isidora Petrović et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Mar 2023
4 citations
275 days before retraction
LncRNAs: Novel therapeutic targets to treat Multiple Myeloma with RNA-based therapies
Ane Amundarain
Unknown Journal Open Access
Published: Jan 2023
361 days before retraction
[SOX2-OT/SOX2 axis regulates lung cancer H520 cell migration via Gli1-mediated epithelial-mesenchymal transition].
Hongliang Dong, Lili Zeng, Yan Wu et al. (8 authors)
PubMed
Published: Oct 2022
1 citation
434 days before retraction
NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis
Chang‐Sheng Wang, Xiaobo Zhang, Xi-Tian Zhu et al. (4 authors)
Neoplasma Open Access
Published: Jan 2022
5 citations
726 days before retraction
Downregulation of SOX2-OT Prevents Hepatocellular Carcinoma Progression Through miR-143-3p/MSI2
Zhao Hongfeng, Minping Bi, Meng Lou et al. (5 authors)
Frontiers in Oncology Open Access
Published: Jul 2021
17 citations
899 days before retraction
Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data
Amit Katiyar, Gurvinder Kaur, Lata Rani et al. (9 authors)
Scientific Reports Open Access
Published: May 2021
20 citations
946 days before retraction
The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma
Arantxa Carrasco‐Leon, Ane Amundarain, Nahia Gómez-Echarte et al. (5 authors)
Cancers Open Access
Published: Apr 2021
14 citations
982 days before retraction
Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling
Nidhi Gupta, Raman Kumar, Alpana Sharma
Molecular and Cellular Biochemistry
Published: Mar 2021
8 citations
1032 days before retraction
Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer
Paul Holvoet
Springer eBooks
Published: Jan 2021
1 citation
1091 days before retraction
Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma
Yafei Yin, Wenqun Yang, Lu Zhang et al. (5 authors)
Hematology Open Access
Published: Jan 2021
20 citations
1091 days before retraction
LncRNA SOX2‐OT regulates AKT/ERK and SOX2/GLI‐1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases
Abril Marcela Herrera‐Solorio, Irlanda Peralta‐Arrieta, Leonel Armas‐López et al. (13 authors)
Molecular Oncology Open Access
Published: Dec 2020
41 citations
1115 days before retraction
The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
Paweł Robak, Izabela Dróźdż, Dariusz Jarych et al. (12 authors)
Cancers Open Access
Published: Sep 2020
29 citations
1205 days before retraction
miR‑144‑3p inhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2A
Fei Tian, Huihan Wang, Huanxin Ma et al. (5 authors)
International Journal of Molecular Medicine Open Access
Published: Jul 2020
10 citations
1270 days before retraction
Long non‐coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA‐143‐3p/c‐MET axis
Yu Tianhua, Li Dianqiu, Xuanhe Zhang et al. (5 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Mar 2020
18 citations
1377 days before retraction
Quick Stats
Total Citations: 18
Years Since Retraction: 1.9 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
miR-129-2-3p inhibits colon cancer cell proliferation by do…
Arab Journal of Gastroenterology • 12 citations
Alpha B-Crystallin Promotes the Invasion and Metastasis of …
Journal of Cellular and Molecular Medicine (JCMM) • 64 citations
HSP27 Associates With Epithelial-Mesenchymal Transition, St…
Journal of Cellular and Molecular Medicine (JCMM) • 34 citations
Circular RNA circFBXO11 Modulates Hepatocellular Carcinoma …
Journal of Cellular and Molecular Medicine (JCMM) • 52 citations